Double Medical Technology Statistics

Total Valuation

Double Medical Technology has a market cap or net worth of CNY 12.59 billion. The enterprise value is 11.73 billion.

Market Cap	12.59B
Enterprise Value	11.73B

Important Dates

The next estimated earnings date is Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	Jun 24, 2024

Share Statistics

Double Medical Technology has 414.02 million shares outstanding. The number of shares has decreased by -0.17% in one year.

Shares Outstanding	414.02M
Shares Change (YoY)	-0.17%
Shares Change (QoQ)	+1.22%
Owned by Insiders (%)	83.90%
Owned by Institutions (%)	5.99%
Float	65.92M

Valuation Ratios

The trailing PE ratio is 123.54 and the forward PE ratio is 36.36.

PE Ratio	123.54
Forward PE	36.36
PS Ratio	7.33
PB Ratio	4.07
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 66.28, with an EV/FCF ratio of -596.99.

EV / Earnings	113.11
EV / Sales	6.71
EV / EBITDA	66.28
EV / EBIT	179.72
EV / FCF	-596.99

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.13.

Current Ratio	2.95
Quick Ratio	1.68
Debt / Equity	0.13
Debt / EBITDA	2.31
Debt / FCF	-20.83
Interest Coverage	6.40

Financial Efficiency

Return on equity (ROE) is 4.23% and return on invested capital (ROIC) is 1.14%.

Return on Equity (ROE)	4.23%
Return on Assets (ROA)	0.93%
Return on Capital (ROIC)	1.14%
Revenue Per Employee	433,327
Profits Per Employee	25,708
Employee Count	4,033
Asset Turnover	0.40
Inventory Turnover	0.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.47% in the last 52 weeks. The beta is 0.20, so Double Medical Technology's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	+0.47%
50-Day Moving Average	25.10
200-Day Moving Average	29.20
Relative Strength Index (RSI)	61.29
Average Volume (20 Days)	2,271,509

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Double Medical Technology had revenue of CNY 1.75 billion and earned 103.68 million in profits. Earnings per share was 0.25.

Revenue	1.75B
Gross Profit	1.10B
Operating Income	65.26M
Pretax Income	155.08M
Net Income	103.68M
EBITDA	166.93M
EBIT	65.26M
Earnings Per Share (EPS)	0.25

Full Income Statement

Balance Sheet

The company has 1.39 billion in cash and 409.13 million in debt, giving a net cash position of 979.06 million or 2.36 per share.

Cash & Cash Equivalents	1.39B
Total Debt	409.13M
Net Cash	979.06M
Net Cash Per Share	2.36
Equity (Book Value)	3.21B
Book Value Per Share	7.47
Working Capital	1.94B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 264.83 million and capital expenditures -284.48 million, giving a free cash flow of -19.64 million.

Operating Cash Flow	264.83M
Capital Expenditures	-284.48M
Free Cash Flow	-19.64M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is 63.02%, with operating and profit margins of 3.73% and 5.93%.

Gross Margin	63.02%
Operating Margin	3.73%
Pretax Margin	8.87%
Profit Margin	5.93%
EBITDA Margin	9.55%
EBIT Margin	3.73%
FCF Margin	-1.12%

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.79%.

Dividend Per Share	0.25
Dividend Yield	0.79%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	76.95%
Buyback Yield	0.17%
Shareholder Yield	0.96%
Earnings Yield	0.81%
FCF Yield	-0.16%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Double Medical Technology has an Altman Z-Score of 7.74.

Altman Z-Score	7.74
Piotroski F-Score	n/a